Virtual Patients...Real Results

Entelos is a life sciences company improving human health through predictive biosimulation. Using in silico disease models and a virtual patient approach, Entelos identifies and validates targets, develops biomarkers, improves the success rates of clinical trials, and helps bring therapeutics to market faster.
News Releases  » Media Coverage  » Events  »
Entelos Agrees to Expanded License Terms with Pfizer -
June  23, 2010
Entelos announces publication of its Type 1 Diabetes PhysioLab® platform, a computer model to aid in the development of novel therapeutic approaches -
June  2, 2010
Entelos and RegeneMed Introduce iToxFX to Help Predict the Safety of New Drugs -
March  8, 2010

Visit Realab™, Entelos' online simulation tool.
It’s the System, Stupid: How Systems Biology is Transforming Health, Disease, and the Life Sciences - Biotechnology Healthcare, Spring 2010
Entelos featured in “The Knowledge Revolution” - PharmaVoice, Digital Edition, September 2009
Today Show interview with author David Ewing Duncan features "The Entelos Prognosis" - Today Show (NBC), March 11, 2009
See how Entelos technology is used to make personal health decisions.
Visit www.MyDigitalHealth.com.
Advancing Biologics from the Lab to the Clinic - Washington, D.C.,
September 16-17
VPH Conference, organised by the Virtual Physiological Human Network of Excellence - Brussels, Belgium,
September 30-October 1
For information on Entelos toxicogenomics solutions including DrugMatrix® and ToxFX™, please visit the Iconix website.
Copyright© 2010 Entelos, Inc. All rights reserved Disclaimer (U.S. Visitors)